skysarah82
About
CONKO-006: A randomised double-blinded stage IIb-study of component remedy with gemcitabine + sorafenib/placebo in sufferers along with R1 resection regarding pancreatic cancer : Benefits.
CONKO-006: A randomised double-blinded stage IIb-study of component remedy with gemcitabine + sorafenib/placebo in sufferers along with R1 resection regarding pancreatic cancer : Benefits.